Article

Fibrinogen and beta-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's Disease

Laboratory of Neurobiology and Genetics, The Rockefeller University, New York, NY 10065, USA.
Neuron (Impact Factor: 15.77). 06/2010; 66(5):695-709. DOI: 10.1016/j.neuron.2010.05.014
Source: PubMed

ABSTRACT Alzheimer's disease (AD) is a neurodegenerative disorder in which vascular pathology plays an important role. Since the beta-amyloid peptide (Abeta) is a critical factor in this disease, we examined its relationship to fibrin clot formation in AD. In vitro and in vivo experiments showed that fibrin clots formed in the presence of Abeta are structurally abnormal and resistant to degradation. Fibrin(ogen) was observed in blood vessels positive for amyloid in mouse and human AD samples, and intravital brain imaging of clot formation and dissolution revealed abnormal thrombosis and fibrinolysis in AD mice. Moreover, depletion of fibrinogen lessened cerebral amyloid angiopathy pathology and reduced cognitive impairment in AD mice. These experiments suggest that one important contribution of Abeta to AD is via its effects on fibrin clots, implicating fibrin(ogen) as a potential critical factor in this disease.

1 Bookmark
 · 
169 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Inflammation-induced vascular endothelial dysfunction can allow plasma proteins to cross the vascular wall causing edema. Proteins may traverse the vascular wall through two main paracellular and transcellular transport pathways. Paracellular transport involves changes in endothelial cell (EC) junction proteins, while transcellular transport involves caveolar transcytosis. Since both processes are associated with filamentous actin formation the two pathways are interconnected. Therefore, it is difficult to differentiate the prevailing role of one or the other pathways during various pathologies causing an increase in vascular permeability. Using a newly developed dual-tracer probing method, we differentiated transcellular from paracellular transport during conditions of increased content of fibrinogen (Fg), called hyperfibrinogenemia (HFg). Roles of cholesterol and sphingolipids in formation of functional caveolae were assessed using a cholesterol chelator, methyl-beta-cyclodextrin (MβCD) and the de novo sphingolipid synthesis inhibitor myriocin. Fg-induced formation of functional caveolae was defined by association and co-localization of sodium-potassium ATPase (Na(+)/K(+)-ATPase) and plasmalemmal vesicle-associated protein-1 (PV-1) using Försters' Resonance Energy Transfer (FRET) and Total Internal Reflection Fluorescence (TIRF) microscopies, respectively. HFg increased permeability of the EC layer mainly through the transcellular pathway. While MβCD blocked Fg-increased transcellular and paracellular transports, myriocin affected only the transcellular transport. Pial venular leakage of albumin was lesser in myriocin-treated HFg mice. HFg induced greater formation of functional caveolae as indicated by co-localization of Na(+)/K(+)-ATPase with PV-1 by FRET and TIRF. Our results suggest that elevated blood levels of Fg alter cerebrovascular permeability mainly by affecting caveolae-mediated transcytosis through modulation of de novo sphingolipid synthesis.
    AJP Cell Physiology 05/2014; 307(2). DOI:10.1152/ajpcell.00305.2013 · 3.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer’s disease (AD) is the most common neurodegenerative cause of dementia in the elderly. AD is accompanied by the accumulation of amyloid peptides in the brain parenchyma and in the cerebral vessels. The sporadic form of AD accounts for about 95% of all cases. It is characterized by a late onset, typically after the age of 65, with a complex and still poorly understood aetiology. Several observations point towards a central role of cerebrovascular dysfunction in the onset of sporadic AD (SAD). According to the “vascular hypothesis”, AD may be initiated by vascular dysfunctions that precede and promote the neurodegenerative process. In accordance to this, AD patients show increased hemorrhagic or ischemic stroke risks. It is now clear that multiple bidirectional connections exist between AD and cerebrovascular disease, and in this new scenario, the effect of amyloid peptides on vascular cells and blood platelets appear to be central to AD. In this review, we analyze the effect of amyloid peptides on vascular function and platelet activation and its contribution to the cerebrovascular pathology associated with AD and the progression of this disease.
    Frontiers in Cellular Neuroscience 03/2015; DOI:10.3389/fncel.2015.00065 · 4.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The neurovascular unit-comprised of glia, pericytes, neurons and cerebrovasculature-is a dynamic interface that ensures physiological central nervous system (CNS) functioning. In disease dynamic remodeling of the neurovascular interface triggers a cascade of responses that determine the extent of CNS degeneration and repair. The dynamics of these processes can be adequately captured by imaging in vivo, which allows the study of cellular responses to environmental stimuli and cell-cell interactions in the living brain in real time. This perspective focuses on intravital imaging studies of the neurovascular unit in stroke, multiple sclerosis (MS) and Alzheimer disease (AD) models and discusses their potential for identifying novel therapeutic targets.
    12/2012; 1(2):87-94. DOI:10.4161/intv.22214

Full-text (2 Sources)

Download
70 Downloads
Available from
May 28, 2014